DUOXA2

DUOXA2 is a transmembrane maturation factor that enables the dual oxidase DUOX2 to fold, traffic, and generate extracellular H2O2 at the cell surface (PMID:18042646, PMID:31513783). It is essential and non-redundant for reconstituting DUOX2 enzymatic activity, and defined loss-of-function mutations (truncations and missense substitutions) abolish DUOX2-dependent H2O2 production (PMID:18042646, PMID:21367925, PMID:28626131, PMID:40510014). DUOXA2 assembles with DUOX2 into an intermolecular disulfide-bonded complex, linking the N-terminal domain of DUOX2 to the two extracellular loops of DUOXA2; this assembly requires prior intramolecular disulfide bond formation within DUOX2 in the ER, such that DUOX2 acts as a chaperone-like partner whose oxidative folding determines the stability and function of DUOXA2 (PMID:25761904). In polarized epithelia DUOXA2 directs DUOX2 to the apical plasma membrane through its C-terminal region, independently of N-glycosylation, whereas the paralog DUOXA1 missorts DUOX2 basolaterally (PMID:39126279). The Duox2/DuoxA2 complex is the most active H2O2-generating module, and the H2O2 it produces can induce DNA damage in expressing cells (PMID:31513783). Transcription of DUOXA2 is co-regulated with DUOX2 by JAK-STAT signaling, induced by IFN-γ via STAT1 and by IL-4/IL-13 via JAK1-STAT6, the two cytokine arms acting antagonistically (PMID:21321110, PMID:23010498). Loss-of-function DUOXA2 variants cause congenital hypothyroidism, frequently in oligogenic combination with other DUOX-system genes (PMID:28626131, PMID:40510014).

1. 2007 High

   Established that DUOXA2 is functionally required for DUOX2 activity, defining it as a maturation factor rather than an incidental partner.

   Evidence In vitro reconstitution with a C-terminal truncation mutant (p.Y246X) in a cell expression system

   PMID:18042646

   Open questions at the time

   • Did not resolve whether the requirement is for folding, trafficking, or catalytic assembly
   • Single mutant; structural basis of the C-terminal requirement unknown
2. 2011 High

   Showed that DUOXA-DUOX heterodimerization is obligatory for enzyme maturation and that DUOXA1 and DUOXA2 are partially redundant, framing maturation factor specificity.

   Evidence In vitro reconstitution with C189R missense mutant plus genetic mapping of a deletion spanning DUOX2/DUOXA1/DUOXA2

   PMID:21367925

   Open questions at the time

   • Extent and physiological limits of DUOXA1/DUOXA2 redundancy not defined
   • Molecular interface of heterodimerization not yet mapped
3. 2011 Medium

   Identified the first transcriptional control of DUOXA2, co-induced with DUOX2 by IFN-γ, placing the maturation factor under immune cytokine regulation.

   Evidence IFN-γ treatment of pancreatic cancer cells, qPCR, pathway inhibition, and STAT1 ChIP on the DUOX2 promoter

   PMID:21321110

   Open questions at the time

   • STAT1 binding shown on DUOX2 promoter; direct DUOXA2 promoter occupancy not demonstrated
   • Requires JAK-STAT1 plus p38-MAPK, but their integration is unresolved
4. 2012 Medium

   Extended transcriptional regulation to the Th2 axis, showing IL-4/IL-13 selectively co-induce DUOX2/DUOXA2 and that IFN-γ antagonizes this, defining cytokine-balanced control.

   Evidence Cytokine treatment of primary thyrocytes and Caco-2 cells, qRT-PCR, H2O2 measurement, JAK-STAT inhibition

   PMID:23010498

   Open questions at the time

   • Direct STAT6 binding to DUOXA2 regulatory elements not shown
   • Mechanism of IFN-γ/IL-4 antagonism unresolved
5. 2015 High

   Defined the physical basis of the complex, demonstrating disulfide bridges between DUOX2 and DUOXA2 extracellular loops and that DUOX2 oxidative folding chaperones DUOXA2 stability.

   Evidence Cysteine mutagenesis, disulfide bond analysis, co-immunoprecipitation, and functional assays

   PMID:25761904

   Open questions at the time

   • No structure of the assembled complex
   • Order of folding events in the ER not fully resolved
6. 2017 Medium

   Confirmed a patient-derived nonsense allele (p.Tyr138*) as loss-of-function, linking DUOXA2 mutation to disrupted DUOX2 activity in congenital hypothyroidism.

   Evidence HEK293 expression with functional reconstitution assay

   PMID:28626131

   Open questions at the time

   • Single method, single lab
   • Genotype-phenotype correlation not established
7. 2019 High

   Localized the active complex to the cell surface and showed it is the most potent H2O2 generator, with DUOXA2 N-glycosylation required for DUOX2 maturation and the product capable of inducing DNA damage.

   Evidence Inducible HEK293 lines, Duolink proximity ligation, H2O2 and DNA damage assays, glycosylation-defective mutants

   PMID:31513783

   Open questions at the time

   • Reconciling the glycosylation requirement here with later finding that glycosylation is dispensable for apical sorting
   • DNA damage relevance to physiological tissue not tested
8. 2024 High

   Revealed a trafficking role: DUOXA2 directs apical sorting of DUOX2 via its C-terminal region independent of N-glycosylation, distinguishing it functionally from DUOXA1.

   Evidence Co-expression in polarized MDCK cells, confocal immunofluorescence, glycosylation-defective mutants

   PMID:39126279

   Open questions at the time

   • Specific apical sorting motif within the C-terminus not mapped
   • Sorting machinery/adaptors recognizing DUOXA2 unknown
9. 2024 Medium

   Connected DUOXA2 induction to mucosal antifungal defense, showing IL-17 signaling drives Duox2/Duoxa2 upregulation upon Candida colonization.

   Evidence Germ-free colonization, IL-17 receptor knockout mice, IL-17A-treated colonoids with H2O2 readout (preprint)

   Open questions at the time

   • Preprint, not peer-reviewed
   • Direct transcriptional mechanism downstream of IL-17 not defined
10. 2025 Medium

    Demonstrated neuro-immune control, with social stress upregulating Duoxa2 in intestinal epithelium specifically through β-adrenergic signaling.

    Evidence Mouse model with pharmacological antagonists; intestinal epithelial gene expression; propranolol β-AR blockade (preprint)

    Open questions at the time

    • Preprint, not peer-reviewed
    • Whether β-AR acts directly on epithelial DUOXA2 transcription is unresolved
11. 2025 Medium

    Broadened the disease genetics, showing multiple DUOXA2 variants impair DUOX2 H2O2 production and that oligogenic DUOX-system mutations are common in congenital hypothyroidism.

    Evidence Targeted/whole-exome sequencing in a patient cohort with in vitro H2O2 functional assays per variant

    PMID:40510014

    Open questions at the time

    • Contribution of individual variants within oligogenic backgrounds hard to isolate
    • Structural mechanism of variant-specific defects not defined

• The structural architecture of the DUOX2-DUOXA2 complex and the molecular machinery recognizing the DUOXA2 C-terminal apical sorting determinant remain unresolved.
• No structure of the assembled complex
• Apical sorting motif and its recognition factors unidentified
• Direct DUOXA2 promoter elements for STAT1/STAT6 not mapped